MUIR GLENN P — SEC insider filings

SEC reporting owner CIK 1181190. 34 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2020-08-07 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
G1 Therapeutics, Inc. (GTHX)Director61 leg · 50,000 sh · $675,000—14
Neuronetics, Inc. (STIM)Director155 legs · 100,171 sh · $85,128—11
REPLIGEN CORP (RGEN)Director10——20
Cytek Biosciences, Inc. (CTKB)Director3——6

Insider filings — MUIR GLENN P

FiledFormIssuerReported transactionsSource
2026-11-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 4,629 · Option exercise (M): 4,629 (derivative) @ $0EDGAR
2026-11-194/ANeuronetics, Inc. (STIM)Grant/award (A): 175,000 @ $1.31EDGAR
2026-11-184Neuronetics, Inc. (STIM)Grant/award (A): 175,000 @ $1.31EDGAR
2026-08-204Cytek Biosciences, Inc. (CTKB)Option exercise (M): 3,086 · Option exercise (M): 3,086 (derivative) @ $0EDGAR
2026-06-124Cytek Biosciences, Inc. (CTKB)Grant/award (A): 55,555 (derivative) @ $0 · Grant/award (A): 29,835 (derivative) @ $0EDGAR
2026-05-294Neuronetics, Inc. (STIM)Grant/award (A): 30,000 @ $0EDGAR
2026-05-184REPLIGEN CORP (RGEN)Grant/award (A): 995 @ $0 · Grant/award (A): 2,239 (derivative) @ $0EDGAR
2026-05-084REPLIGEN CORP (RGEN)Option exercise (M): 2,434 @ $38.76 · Option exercise (M): 2,434 (derivative) @ $0EDGAR
2025-12-174REPLIGEN CORP (RGEN)Option exercise (M): 3,366 @ $26.12 · Option exercise (M): 3,366 (derivative) @ $0EDGAR
2025-10-224Neuronetics, Inc. (STIM)Grant/award (A): 7,554 @ $0EDGAR
2025-05-274Neuronetics, Inc. (STIM)Grant/award (A): 30,000EDGAR
2025-05-194REPLIGEN CORP (RGEN)Grant/award (A): 973 @ $0 · Grant/award (A): 1,800 (derivative) @ $0EDGAR
2025-02-104Neuronetics, Inc. (STIM)Other (J): 44,444 @ $2.25EDGAR
2024-11-204REPLIGEN CORP (RGEN)Option exercise (M): 19,000 @ $36.29 · Option exercise (M): 19,000 (derivative) @ $0EDGAR
2024-09-184G1 Therapeutics, Inc. (GTHX)Disposition to issuer (D): 20,000 · Code (U): 185,358 · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 50,000 (derivative)EDGAR
2024-09-064Neuronetics, Inc. (STIM)Purchase (P): 25,000 @ $0.80EDGAR
2024-08-304Neuronetics, Inc. (STIM)Purchase (P): 12,776 @ $0.85 · Purchase (P): 12,224 @ $0.85EDGAR
2024-08-214Neuronetics, Inc. (STIM)Purchase (P): 25,000 @ $1EDGAR
2024-08-164Neuronetics, Inc. (STIM)Purchase (P): 25,171 @ $0.75EDGAR
2024-08-014REPLIGEN CORP (RGEN)Option exercise (M): 5,000 @ $36.29 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2024-06-144G1 Therapeutics, Inc. (GTHX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-06-054Neuronetics, Inc. (STIM)Grant/award (A): 25,000EDGAR
2024-05-204REPLIGEN CORP (RGEN)Grant/award (A): 701 @ $0 · Grant/award (A): 1,376 (derivative) @ $0EDGAR
2023-06-164G1 Therapeutics, Inc. (GTHX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-05-304Neuronetics, Inc. (STIM)Grant/award (A): 36,364EDGAR
2023-05-224REPLIGEN CORP (RGEN)Grant/award (A): 686 @ $0 · Grant/award (A): 1,487 (derivative) @ $0EDGAR
2022-06-244G1 Therapeutics, Inc. (GTHX)Grant/award (A): 10,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-05-314REPLIGEN CORP (RGEN)Grant/award (A): 534 @ $0 · Grant/award (A): 1,298 (derivative) @ $0EDGAR
2022-05-314Neuronetics, Inc. (STIM)Grant/award (A): 38,910EDGAR
2021-06-214G1 Therapeutics, Inc. (GTHX)Grant/award (A): 4,389 @ $0 · Grant/award (A): 19,620 (derivative) @ $0EDGAR
2021-06-014Neuronetics, Inc. (STIM)Grant/award (A): 7,137EDGAR
2021-05-174REPLIGEN CORP (RGEN)Grant/award (A): 457 @ $0 · Grant/award (A): 1,151 (derivative) @ $0EDGAR
2020-11-194G1 Therapeutics, Inc. (GTHX)Purchase (P): 50,000 @ $13.50EDGAR
2020-08-074Neuronetics, Inc. (STIM)Grant/award (A): 18,513EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1181190 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs